Article ID Journal Published Year Pages File Type
10920125 Radiotherapy and Oncology 2005 7 Pages PDF
Abstract
On present evidence, in the settings of a developing country, CBRT with concurrent cisplatin cannot be recommended as primary therapy in advanced head and neck cancers without formal comparison with other treatment modalities.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial
Authors
, , , , , ,